Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Anticoagulant Assays for New Anticoagulants and Their Reversibility in Vitro

NCT01795781 is registered in ClinicalTrials.gov with R.P.Herrmann as lead sponsor.

NCT NCT01795781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01795781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Anticoagulant Assays for New Anticoagulants and Their Reversibility in Vitro
Lead sponsor
R.P.Herrmann
Phase
Observational
Overall status
Completed
Start date
April 30, 2012
Completion date
April 30, 2013
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, osteoarthritis of the hip, osteoarthritis of the knee